Published

Toward Standardized Products Containing Biomass of Psilocybe Cubensis Fungi.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of AOAC International
Date: 2026-01-01
Source: PubMed
DOI: 10.1093/jaoacint/qsaf072
PubMed: 40802522

Authors

Foster K Morrison I Daniel S Antoine J Thankappan B De La Haye W Tyler M Grant C Delgoda R

Watch author

Derived topics and classifications

psilocybin psilocin Wellbeing Clinical Trial Healthcare Workers Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 5 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from Jamaica2026-07-29 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03 Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA2026-06-15 Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapy2026-06-02 Toward Standardized Products Containing Biomass of Psilocybe Cubensis Fungi.2026-01-01

Related papers

No close related records were found yet.